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Abstract
Background: Mindful-based interventions improve functioning and quality of life in fibromyalgia (FM) patients. The
aim of the study is to perform a psychometric analysis of the Spanish version of the Mindful Attention Awareness
Scale (MAAS) in a sample of patients diagnosed with FM.
Methods: The following measures were administered to 251 Spanish patients with FM: the Spanish version of
MAAS, the Chronic Pain Acceptance Questionnaire, the Pain Catastrophising Scale, the Injustice Experience
Questionnaire, the Psychological Inflexibility in Pain Scale, the Fibromyalgia Impact Questionnaire and the Euroqol.
Factorial structure was analysed using Confirmatory Factor Analyses (CFA). Cronbach's α coefficient was calculated
to examine internal consistency, and the intraclass correlation coefficient (ICC) was calculated to assess the
test-retest reliability of the measures. Pearson’s correlation tests were run to evaluate univariate relationships
between scores on the MAAS and criterion variables.
Results: The MAAS scores in our sample were low (M = 56.7; SD = 17.5). CFA confirmed a two-factor structure, with
the following fit indices [sbX2 = 172.34 (p < 0.001), CFI = 0.95, GFI = 0.90, SRMR = 0.05, RMSEA = 0.06. MAAS was
found to have high internal consistency (Cronbach’s α = 0.90) and adequate test-retest reliability at a 1–2 week
interval (ICC = 0.90). It showed significant and expected correlations with the criterion measures with the exception
of the Euroqol (Pearson = 0.15).
Conclusion: Psychometric properties of the Spanish version of the MAAS in patients with FM are adequate. The
dimensionality of the MAAS found in this sample and directions for future research are discussed.
Keywords: Mindfulness, MAAS, Reliability, Validity, Fibromyalgia
Background
In the last 20 years, an increasing number of studies
have been dedicated to research on mindfulness and the
use of mindfulness training as a clinical intervention for
diverse physical and mental disorders. Mindfulness
refers to an awareness that emerges by paying attention
to purpose and to the present moment and non-
judgmentally focusing on the unfolding of one’s immedi-
ate experience [1,2]. Mindfulness is a skill that can be
taught using several uniquely designed techniques [3].
Mindfulness-based therapies have been demonstrated
to be effective for the treatment of many disorders, in-
cluding chronic pain conditions [4-6]. The mechanisms
underlying the effects that mindfulness training has on
health are diverse and include increased attention con-
trol, increased awareness of inner experiences, increased
emotional regulation, and changes in the concept of self
or in body awareness [7].
Mindfulness training in the treatment of fibromyalgia
(FM) has been shown to decrease pain symptoms and to
improve overall quality of life; as such, mindfulness
training is considered a promising supplement to
current interventions [4,8-10]. Despite these findings,
there is still a lack of understanding of the mechanisms
that underlie the mitigating effects of mindfulness on
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pain symptoms. Research studies on such mitigating
effects suggest that mindfulness alters the contextual
evaluation of pain [5], reduces pain catastrophising and
pain sensitivity [6], reduces psychopathological symp-
toms [11,12], and alters pain-related anxiety [13]. These
results have not been contradicted in the three years
since their discovery [9].
Recent findings suggest that pain acceptance, which is
promoted by mindfulness interventions, improves func-
tioning and life quality. However, there is still a lack of
reliable and valid instruments to assess relevant pro-
cesses in such interventions [14]. It is assumed that if
mindfulness is a learned skill, then a measure of mind-
fulness should demonstrate both incremental validity
[15] and sensitivity to change. Furthermore, the expected
changes (for example, improvement in quality of life or
decrease in symptoms) should be directly related to
changes in mindfulness.
There are several questionnaires that measure mind-
fulness, with the two the most commonly used being the
Five-Facets Mindfulness Questionnaire (FFMQ) [16] and
the Mindful Attention Awareness Scale (MAAS) [17].
The FFMQ is considered one of the most complete
questionnaire because it measures five component skills
of mindfulness: observing, describing, acting with aware-
ness, nonjudging of inner experience and nonreactivity
to inner experience. However, the MAAS is the most
popular scale measuring mindfulness, with over 350 cita-
tions in the Web of Science [18]. The MAAS has shown
theoretically consistent relationships to brain activity
[19], treatment outcome in mindfulness-based inter-
ventions (MBIs) [20] and mediation of targeted MBI
outcomes [21].
The authors that developed the MAAS define mindful-
ness as “the presence or absence of attention to, and
awareness of, what is occurring in the present moment”.
The MAAS is a 15-item scale developed to measure the
frequency of mindful states in daily life. Translated var-
iants of this scale have been validated in several lan-
guages, including Spanish [22], Chinese [23], Swedish
[24], Turkish [25] and French [26].
The original Spanish scale was validated and devel-
oped in a sample of Spanish non-clinical participants.
[22]. Within the clinical population, the MAAS has been
validated only in a sample of cancer patients [27]. The
validation of scales in specific clinical samples is import-
ant for research on mindfulness due to the recognised
need for using valid measures in the assessment of inter-
ventions. In a recent study, the Five Facets of Mindful-
ness Inventory was validated in a sample of patients
diagnosed with fibromyalgia. The results from this study
showed that the data taken from the patient sample had
a similar factorial structure to data taken from a healthy
sample [28]. The purpose of the present study is to
examine the psychometric properties of the Spanish ver-
sion of the MAAS in a sample of patients diagnosed
with fibromyalgia.
Method
Sample and procedure
Sample size was calculated according to the recommen-
ded 10:1 ratio of the number of subjects to the number
of test items [29]. Participants were recruited from the
Pain Clinic (Santander, Spain) and the Fibromyalgia Unit
of the Miguel Servet Hospital, Zaragoza (Spain). Recruit-
ment took place during the year 2010. To be included in
the study, patients had to be diagnosed with fibromyalgia
by a rheumatologist according to American College of
Rheumatology (ACR) criteria [30]. Patients were exclu-
ded if they had a medical or psychiatric disorder that im-
peded their ability to correctly answer the questionnaire.
The sample consisted of 251 participants (10 men and
241 women), with a mean age of 52.4 years (SD = 8.4;
Range = 31–70). One patient was excluded as a result
of being diagnosed with schizophrenia, which, in the
clinician’s point of view, limited the reliability of the
questionnaire. On average, participants had suffered from
FM for 7.9 years (SD = 2.3; range = 1–20), and 122 partici-
pants (48.8%) had been granted an invalidity pension. The
majority of patients (N = 231; 92.4%) were taking one or
more prescription drug. More than half of the patients
(N = 131; 52.4%) suffered from some form of psychiatric
morbidity, as assessed by the MINI Psychiatric Inter-
view [31] (mainly depression and anxiety). A group of
21 patients (8.4%) were also diagnosed with Posttrau-
matic Stress Disorder. The study questionnaires and pro-
tocol were approved by the Ethical Committee of the
regional health authority, and patients signed a con-
sent form attesting to their willingness to participate in
the study.
Instruments
Mindful attention awareness scale (MAAS)
The MAAS is a 15-item instrument measuring the gen-
eral tendency to be attentive to and aware of one’s
experiences in daily life [17]. Using a 6-point Likert-
type scale (ranging from almost always to almost
never), respondents rated how often they experienced
acting as if they were on automatic pilot, being pre-
occupied, and not paying attention to the present mo-
ment (e.g.: “I could be experiencing some emotion and
not be conscious of it until some time later”)..The scale
showed an internal consistency of 0.82 and exhibited
significant convergent and discriminant validity. Scores
on the MAAS were significantly higher in mindfulness
practitioners than in matched community controls. The
Spanish version of the MAAS was used, and it has re-
cently been shown to have good test-retest reliability
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and internal consistency in a sample of healthy Spanish
subjects [22].
Chronic pain acceptance questionnaire (CPAQ)
The CPAQ is a 20-item questionnaire designed to meas-
ure pain acceptance (e.g.: “It’s OK to experience pain”)
[32]. All items are rated on a Likert-type scale, ranging
from 0 (never true) to 6 (always true). The Spanish ver-
sion of the scale has been validated [33], showing suffi-
cient test-retest reliability and internal consistency.
Pain catastrophizing scale (PCS)
The PCS is a 13-item scale designed to assess individuals’
catastrophising cognitions by asking them to reflect on
thoughts or feelings associated with present painful
experiences (e.g.: “When I’m in pain I feel I can’t go on”)
[34]. Each item is scored on a Likert-type scale, which
ranges from 0 (not at all) to 4 (always). The Spanish ver-
sion of this scale has been validated, [35] showing suffi-
cient test-retest reliability and internal consistency.
Injustice experience questionnaire (IEQ)
The IEQ is a 12-item questionnaire that measures the
frequency with which patients have thoughts concern-
ing the unfairness of their illness (e.g.: “My life will
never be the same”) [36]. Each question is answered
using a 5-point scale, which ranges from 0 (never) to 4
(all the time). The Spanish version of this scale has
been validated, [37] showing sufficient test-retest reli-
ability and internal consistency.
The psychological inflexibility in pain scale (PIPS)
The PIPS [14] is a 12-item scale developed to assess tar-
get variables in exposure and acceptance-oriented treat-
ments of chronic pain (e.g.: “I postpone things because
of my pain”). We used the total scores resulting from
this instrument in the final analyses of this study. The
Spanish version of PIPS has been validated by our group
“(personal communication)”.
EuroQol (EQ-5D)
The EQ-5D is a questionnaire composed of 7 items
developed to measure a unique health status score [38].
The EQ-5D covers 5 dimensions of health: mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression. Each dimension is evaluated in 3 categories
(no problem, moderate problems, or extreme problems).
In the present study, we used a validated Spanish version
of EQ-5D [39].
Fibromyalgia impact questionnaire (FIQ)
The Fibromyalgia Impact Questionnaire (FIQ) is a 10-item
self-report questionnaire developed to measure the func-
tional impairment of fibromyalgia patients [40]. The first
item of the scale focuses on the patient's ability to carry
out muscular activities. The next two items of the scale ask
patients to indicate the number of days in the past week
that they felt good and the number of instances that they
missed work. Finally, the last seven items (i.e., ability to
work, pain, fatigue, morning tiredness, stiffness, anxiety
and depression) are measured with visual analogue scales.
The Spanish version of this scale has been validated [41].
Statistical analyses
Demographic data were analysed using the descriptive
statistics of mean, standard deviation (SD) and range.
Prior to conducting the statistical analyses, we examined
data for univariate and multivariate outliers. In order to
detect the presence of univariate outliers, the frequency
distributions of each item was examined (values ≥ 3
standard deviations from the mean indicate univariate
outliers). Screening for multivariate outliers was by car-
ried out by means of the Mahalanobis distance scores
for all cases (D2); A D2 probability ≤ 0.01 indicates the
existence of multivariate outliers [42]. We did not detect
any outliers, therefore all cases were retained for the
statistical analyses.
We used Confirmatory Factor Analysis (CFA) to ana-
lyse the dimensionality of the MAAS. We propose a
one-factor model (with all items loading on one latent
factor) and a two-factor model (Factor 1: items 1, 2, 4, 5,
7, 8, 9, 10, 11, 14, and 15; Factor 2: items 3, 6, 12, and
13) previously found with a principal component ana-
lysis. EQS software for Windows version 6.1 [43] was
used to conduct the CFA. The maximum likelihood
with robust correction method was used to adjust for
distributional problems in the data set. Although a
model with a non-significant chi-square estimate is
generally considered a model with good fit, Hu and
Bentler [44] recommended combinational rules to
evaluate model fit. Therefore, we analysed the follow-
ing indices (values in parentheses denote goodness of
fit standards): Comparative Fit Index and Goodness of
Fit Index (CFI and GFI > 0.90) and Root Mean Square
Error of Approximation and Standardized Root Mean-
Square Residual (RMSEA and SRMR < 0.08). The
Satorra–Bentler chi-square is a chi square fit index
that corrects the statistic under distributional viola-
tions. To reduce the sensitivity of chi-square to sam-
ple size, the index is divided by the degrees of
freedom. Ratios of 3 or smaller are indicative of an
acceptable fit of the model [45]. We selected these
statistics to measure fit because previous research cor-
roborated their performance and stability [46].
We examined the internal consistency, test-retest, and
construct validity of the MAAS. Cronbach's α coefficient
[47] was used to analyse the internal consistency of the
scale. Corrected item-total correlations, in which an item
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is correlated with the total scale score excluding itself,
were tested for each item. Consistency of the MAAS
total score over time (test-retest reliability) was assessed
using the Intraclass Correlation Coefficient (ICC). Con-
struct validity was examined by correlating the MAAS
with theoretically related and unrelated constructs. Pear-
son’s correlations were performed to evaluate univariate
relationships between the MAAS and the following cri-
terion variables: chronic pain acceptance, pain catastro-
phising, perceived injustice, pain inflexibility, global
function and quality of life. We used effect size criteria
outlined by Cohen [48] to evaluate the substantive sig-
nificance of correlations (i.e., large correlations are those
>0.50, medium correlations range from 0.30 to 0.49, and
small correlations range from 0.10 to 0.29).
Results
All items were examined in terms of mean, standard de-
viation, skewness and kurtosis. Univariate values
approaching at least 2.0 for skewness and 7.0 for kur-
tosis indicate marked non-normality [42]. On the basis
of the values displayed in Table 1, the data appear to
show normality.
As shown in Table 1, descriptive statistics were computed
for all MAAS items. The mean total score on the MAAS
was 56.7 (SD = 17.5; range 18–90). The highest score was
obtained for item 5, which asks about the subject’s tendency
not to notice feelings of physical tension and discomfort
until these symptoms grab his or her attention. The lowest
score was obtained for item 6, which asks about the ten-
dency to forget the name of a person immediately.
Table 1 Means (M), standard deviation (SD), 95% Confidence Intervals (95% CIs), standardised factor loadings (λ one-factor
solution), corrected item-total correlations (rtot), skewness and kurtosis for all MAAS items
MAAS items (Spanish translation between parentheses) M (SD) 95% CIs λ rtot Skewness Kurtosis
1. I could be experiencing some emotion and not be conscious of it until some time
later (Puedo estar experimentando alguna emoción y no ser consciente hasta
algún tiempo después)
4.39 (1.6) 4.1-4.6 0.53 0.53 -.44 −1.22
2. I break or spill things because of carelessness, not paying attention, or thinking of
something else (Rompo o derramo cosas por descuido, por no prestar atención
o por pensar en otra cosa).
4.15 (1.7) 3.9-4.3 0.60 0.59 -.30 −1.38
3. I find it difficult to stay focused on what’s happening in the present (Encuentro
difícil permanecer focalizado en lo que está ocurriendo en el presente).
3.34 (1.7) 3.1-3.5 0.60 0.59 .32 −1.13
4. I tend to walk quickly to get where I’m going without paying attention to what I
experience along the way (Tiendo a andar rápidamente para llegar a donde quiero
ir sin prestar atención a lo que experimento a lo largo del camino).
3.82 (1.8) 3.5-4 0.59 0.62 -.08 −1.50
5. I tend not to notice feelings of physical tension or discomfort until they really grab
my attention (Tiendo a no notar la tensión física o el malestar hasta que realmente
despierta mi atención).
4.61 (1.7) 4.4-4.8 0.44 0.42 -.83 -.82
6. I forget a person’s name almost as soon as I’ve been told it for the first time (Olvido
el nombre de una persona casi tan pronto como me lo dicen por primera vez).
2.14 (1.6) 1.9-2.3 0.34 0.32 1.32 .37
7. It seems that I am “running on automatic pilot,” without much awareness of what
I’m doing (Parece que lleve puesto el “piloto automático” sin ser consciente de lo
que estoy haciendo).
3.31 (1.8) 3-3.5 0.81 0.76 .32 −1.29
8. I rush through activities without being really attentive to them. (Hago las actividades
diarias corriendo sin estar realmente atento a ellas).
4.01 (1.7) 3.7-4.2 0.80 0.72 -.18 −1.46
9. I get so focused on the goal I want to achieve that I lose touch with what I’m doing
right now to get there (Estoy tan centrado en la meta que quiero alcanzar que pierdo
la noción de lo que estoy haciendo).
4.37 (1.8) 4.1-4.6 0.81 0.76 -.55 −1.28
10. I do jobs or tasks automatically, without being aware of what I'm doing (Hago tareas
o trabajos automáticamente sin ser consciente de lo que estoy haciendo).
4.08 (1.8) 3.8-4.3 0.82 0.75 -.28 −1.47
11. I find myself listening to someone with one ear, doing something else at the
same time. (Me encuentro a mí mismo escuchando a alguien mientras hago algo al
mismo tiempo).
3.81 (1.7) 3.6-4 0.47 0.45 .03 −1.52
12. I drive places on “automatic pilot” and then wonder why I went there (Conduzco a
sitios con el “piloto automático” y entonces me pregunto qué hago allí).
3.47 (1.9) 3.2-3.7 0.66 0.65 .14 −1.52
13. I find myself preoccupied with the future or the past (Me encuentro a mí mismo
preocupado por el futuro o el pasado).
3.04 (1.8) 2.8-3.2 0.42 0.42 .50 −1.14
14. I find myself doing things without paying attention (Me encuentro a mí mismo
haciendo cosas sin prestar atención).
3.68 (1.7) 3.4-3.9 0.80 0.76 .10 −1.39
15. I snack without being aware that I’m eating (Picoteo sin ser consciente de lo que
estoy comiendo).
4.52 (1.9) 4.2-4.7 0.49 0.48 -.81 −1.01
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Confirmatory factor analysis (CFA)
The original one-factor model [16] showed good fit indices
[sbX
2 = 185.43 (p < 0.001); CFI = 0.94; GFI = 0.89; SRMR=
0.05; RMSA= 0.07 (0.05-0.08)]. The two-factor model,
based on a previous exploratory factor analysis, obtained
slightly better fit indices [sbX
2 = 172.34 (p < 0.001), CFI =
0.95, GFI = 0.90, SRMR= 0.05, RMSEA = 0.06 [0.05-0.08]].
The factor loadings of all MAAS items are shown in
Table 1.
Reliability
Cronbach’s α for the MAAS was 0.90, indicating a
high degree of internal consistency. Corrected item-
total r correlation coefficients ranged between 0.32 and
0.76. With regard to temporal stability, a subsample of
162 patients from the original sample was randomly
selected and contacted by phone in order to arrange a new
interview to complete the instruments again 1–2 weeks
later. This subsample included 5 men and 156 women,
with a mean age of 50.8 years (SD = 7.9; Range = 33–68).
Data from this subsample showed a test-retest coefficient
of 0.90 (CI = 0.89–0.92).
Construct validity
The convergent and divergent validity of the MAAS was
calculated using Pearson’s product–moment correlations
with other relevant measures of psychopathology and
measures of level of acceptance related to pain (see
Table 2). Overall, with the exception of the EQ-5D, the
measures correlated moderately and significantly with
total scores on the MAAS.
Discussion
The main objective of this study was to examine the psy-
chometric properties of the Spanish version of the
MAAS in a sample of patients with fibromyalgia. The
MAAS scoring in our sample of patient s with FM (N =
251; M = 3.78; SD = 1.68) compared with the community
adults sample studied in the original validation study
(17) (N = 436; M = 4.20, SD = .69) is significantly lower
(t = −4.592; gl = 685; p <0.001). These data show a ten-
dency of FM patients to be less aware of their experience
in daily life, acting more on “autopilot” and paying less
attention to the present moment than healthy popula-
tion does. A descriptive analysis of the items and the
total score showed a tendency of FM patients to be less
aware of their experience in daily life, acting more on
“autopilot” and paying less attention to the present mo-
ment than healthy population does.
The results found using CFA are largely consistent
with those reported in previous studies [17,22-27,49]. In
the current sample, the one- and two-factor models both
show adequate fit; however, we decided to retain the
one-factor model for the set of reasons outlined below.
First, the one-factor model met all the pre-established fit
criteria, except for the chi-squared goodness-of-fit statis-
tic, which was statistically significant (an unsurprising
result, given that this statistic is highly sensitive and even
small differences in model fit are statistically significant).
Second, with the exception of item 6, all items loaded
strongly on the latent factor (all factor loadings exceeded
0.40). Third, the underlying construct of the second la-
tent factor in the two-factor model is difficult to inter-
pret, other than on the basis of the item difficulty of the
4 loaded items. For instance, forgetting another person’s
name almost as soon as one has been introduced for the
first time is quite common, even amongst healthy indivi-
duals; this item had the lowest mean score. The two-
factor model was proposed on the basis of a previous ex-
ploratory factor analysis, and it is well known that
“artifactual difficulty” factors may be generated in unidi-
mensional instruments when using exploratory techni-
ques [50]. Fourth, the one-factor structure of the MAAS
gained further support from the internal consistency
analysis, which yielded an excellent Cronbach's α. Fifth,
all items showed a corrected item-total correlation that
was higher than conventional minimum value of 0.20.
The test-retest reliability analysis yielded good tem-
poral stability in a 1–2 week period. Regarding the cor-
relation analyses, almost all of the measures included in
the study correlated in the expected way with the MAAS
total scores. These results are consistent with those
found in other studies that demonstrate the importance
of acceptance capacity in the experience of pain [5,6].
The only exception to this pattern of findings was the
correlations between the MAAS and EQ-5D. However,
these data are not surprising, given the results found by
Boomershine [51], who performed a comprehensive
evaluation of standardised assessment tools in the
diagnosis of the fibromyalgia syndrome and in the
assessment of fibromyalgia severity. In this evalu-
ation, the EQ-5D was not among the recommended
Table 2 Means (M) and standard deviations (SD) of study
measures and association with MAAS total score in
fibromyalgia patients
M (SD) MAAS
CPAQ 47.6 (23.3) 0.37**
PCS 24.3 (13.6) −0.47**
FIQ 58.0 (15.0) −0.46**
EIQ 30.1 (12.1) −0.45**
PIPS 57.1 (18.2) −0.47**
EQ-5D 47.1 (19.8) 0.15*
*p < 0.05; ** p < 0.001.
MAAS =Mindful Attention Awareness Scale; CPAQ = Chronic Pain Acceptance
Questionnaire; PCS = Pain Catastrophizing Scale; FIQ = Fibromyalgia Impact
Questionnaire; IEQ = Injustice Experience Questionnaire; PIPS = The
Psychological Inflexibility in Pain Scale; EQ-5D = Health-related quality of life.
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instruments for assessing HRQL or global improve-
ment in these patients with FM.
The two-factor structure was best supported by the
data found in this research study, but results are not
strong enough to conclude that this factorial model is
best for the reasons already described. In both cases (uni
and bifactorial models), the factor structure exhibited an
acceptable fits, although more research is needed to ex-
plore the stability of the factor structure in FM and
other chronic pain patients.
This study has several limitations. First, as in any study
using self-report measures, the results may have been
influenced by participants’ acquiescence and need for so-
cial desirability. Furthermore, the validity of self-report
measures of mindfulness, and the MAAS in particular,
have been criticised previously [18]. One such criticism
is that respondents might not be fully aware of their
ability to experience the present moment. Second, we
did not assess the instrument in populations of patients
with other types of chronic pain, thus we did not con-
firm whether the factor structure is or is not specific to
fibromyalgia. Third, the overwhelming proportion of
women limits the generalizability of the findings to men.
And finally, the difficulty in interpreting the confirma-
tory factor analyses warrants more research studies.
Conclusion
In conclusion, the MAAS has been shown to be a reli-
able instrument for measuring mindfulness in fibromyal-
gia patients. The results found through the factor
structure analyses in this study should be examined in
future studies. Such studies may compare the current
results with those taken from clinical samples suffering
from other types of chronic pain.
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